- Home
- KIDS vs DNA Comparison
KIDS vs DNA Comparison
Compare KIDS & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- DNA
- Stock Information
- Founded
- KIDS 2007
- DNA 2008
- Country
- KIDS United States
- DNA United States
- Employees
- KIDS N/A
- DNA N/A
- Industry
- KIDS Medical/Dental Instruments
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KIDS Health Care
- DNA Health Care
- Exchange
- KIDS Nasdaq
- DNA Nasdaq
- Market Cap
- KIDS 479.7M
- DNA 552.0M
- IPO Year
- KIDS 2017
- DNA N/A
- Fundamental
- Price
- KIDS $19.19
- DNA $13.18
- Analyst Decision
- KIDS Strong Buy
- DNA Hold
- Analyst Count
- KIDS 7
- DNA 2
- Target Price
- KIDS $34.14
- DNA $8.50
- AVG Volume (30 Days)
- KIDS 188.7K
- DNA 1.8M
- Earning Date
- KIDS 08-05-2025
- DNA 08-07-2025
- Dividend Yield
- KIDS N/A
- DNA N/A
- EPS Growth
- KIDS N/A
- DNA N/A
- EPS
- KIDS N/A
- DNA N/A
- Revenue
- KIDS $220,733,000.00
- DNA $230,815,000.00
- Revenue This Year
- KIDS $19.23
- DNA N/A
- Revenue Next Year
- KIDS $17.14
- DNA $15.91
- P/E Ratio
- KIDS N/A
- DNA N/A
- Revenue Growth
- KIDS 26.08
- DNA 25.21
- 52 Week Low
- KIDS $16.59
- DNA $5.00
- 52 Week High
- KIDS $33.14
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- KIDS 40.61
- DNA 55.24
- Support Level
- KIDS $18.63
- DNA $11.41
- Resistance Level
- KIDS $20.48
- DNA $13.44
- Average True Range (ATR)
- KIDS 1.17
- DNA 1.14
- MACD
- KIDS -0.14
- DNA -0.17
- Stochastic Oscillator
- KIDS 41.27
- DNA 53.55
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.